NIH-funded research R01 grant

Excitability dysfunction in ALS and FTD linked to TDP-43

Official title: Excitability dysfunction mechanisms underlying the TDP43-dependent ALS and FTD pathogenesis

Funded at Wright State University · NIH-11601035 · Data updated 2026-11-12

A patient-focused research opportunity to understand how nerve cell electrical activity goes wrong in ALS and related dementia linked to TDP-43.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWright State University
NIH-funded
Lab location1 site (Dayton, United States)
Project startAugust 1, 2023
Project endJuly 31, 2028
Funding year2026
Award (this year)$33,512
NIH project number3R01NS131816-04S1
Project IDNIH-11601035 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with ALS or ALS-FTD spectrum conditions whose disease mechanism may involve TDP-43 pathology, informing future translational strategies.

Less likely to help

Patients without TDP-43–related pathology or those not eligible for future translational trials may see limited direct benefit.

What this research studies

This project studies how motor nerve cells lose or gain electrical control in ALS and related frontotemporal dementia, using a mouse model that mimics human TDP-43 pathology to uncover when excitability becomes harmful or protective. By comparing new rNLS8 mice with prior ALS models, researchers aim to map when and where excitability changes happen in brain and spinal cord. The goal is to translate these insights into targets that could slow or protect neurons in people living with ALS or FTD. The work will involve detailed physiological measurements and analysis of neuronal circuits to clarify conflicting findings from earlier studies.

Why it matters

Potential benefit: If successful, the findings could guide development of therapies that stabilize motor neuron excitability and potentially slow disease progression in ALS and related dementias.

How similar studies have gone: Previous ALS models showed both increased and decreased excitability; this project extends that work to a human-relevant TDP-43 model, with potential for clear translational relevance.

Where this research is happening

  • Wright State University
    Dayton, United States
    Active

Researchers

  • Principal investigator: Elbasiouny, Sherif M — Wright State University
  • Study coordinator: Elbasiouny, Sherif M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.